Abstract
Background The purpose of this study is to determine whether revision total hip arthroplasty (THA) is associated with increased rates of deep vein thrombosis (DVT) and pulmonary embolism (PE) when compared to primary THA. Methods We queried the American College of Surgeons National Surgical Quality Improvement Program database for all primary and revision THA cases from 2011 to 2014. Demographic data, medical comorbidities, and venous thromboembolic rates within 30 days of surgery were compared between the primary and revision THA groups. Results Revision THA had a higher rate of DVT than the primary THA (0.6% vs 0.4%, P =.016), but there was no difference in the rate of PE (0.3% vs 0.2%, P =.116). When controlling for confounding variables, revision surgery alone was not a risk factor for DVT (odds ratio 0.833, 95% confidence interval 0.564-1.232) or PE (odds ratio 1.009, 95% confidence interval 0.630-1.616). Independent risk factors for DVT include age >70 years, malnutrition, infection, operating time >3 hours, general anesthesia, American Society of Anesthesiologists classification 4 or greater, and kidney disease (all P 70 years, African American ethnicity, and operating time >3 hours (all P
Author supplied keywords
Cite
CITATION STYLE
Courtney, P. M., Boniello, A. J., Levine, B. R., Sheth, N. P., & Paprosky, W. G. (2017). Are Revision Hip Arthroplasty Patients at Higher Risk for Venous Thromboembolic Events Than Primary Hip Arthroplasty Patients? Journal of Arthroplasty, 32(12), 3752–3756. https://doi.org/10.1016/j.arth.2017.07.028
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.